Evidence map›Paper›PMID 27647142›Full record

ArticleBMC complementary and alternative medicine2016

Anti-proliferative and anti-migration effects of Polish propolis combined with Hypericum perforatum L. on glioblastoma multiforme cell line U87MG.

Maria H Borawska, Sylwia K Naliwajko, Justyna Moskwa, Renata Markiewicz-Żukowska, Anna Puścion-Jakubik, Jolanta Soroczyńska

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Complementary and Alternative Therapies in Oncology.International journal of environmental research and public health · 2022
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Maria H BorawskaDepartment of Bromatology, Faculty of Pharmacy with Division of Laboratory Medicine, Medical University of Bialystok, Mickiewicza 2D, 15-222, Bialystok, Poland. bromatos@umb.edu.pl.
Sylwia K NaliwajkoDepartment of Bromatology, Faculty of Pharmacy with Division of Laboratory Medicine, Medical University of Bialystok, Mickiewicza 2D, 15-222, Bialystok, Poland.
Justyna MoskwaDepartment of Bromatology, Faculty of Pharmacy with Division of Laboratory Medicine, Medical University of Bialystok, Mickiewicza 2D, 15-222, Bialystok, Poland.
Renata Markiewicz-ŻukowskaDepartment of Bromatology, Faculty of Pharmacy with Division of Laboratory Medicine, Medical University of Bialystok, Mickiewicza 2D, 15-222, Bialystok, Poland.
Anna Puścion-JakubikDepartment of Bromatology, Faculty of Pharmacy with Division of Laboratory Medicine, Medical University of Bialystok, Mickiewicza 2D, 15-222, Bialystok, Poland.
Jolanta SoroczyńskaDepartment of Bromatology, Faculty of Pharmacy with Division of Laboratory Medicine, Medical University of Bialystok, Mickiewicza 2D, 15-222, Bialystok, Poland.
Medical University of Białystok · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPropolis and Hypericum perforatum L. are natural products which contain many active compounds and have numerous beneficial effects, including an antitumor effect. Gliobmastoma multiforme (GBM) is a common primary brain tumor with poor prognosis and limited treatment options. In this study, the effect of propolis (EEP) combined with H. perforatum L. (HPE) on glioblastoma cell line U87MG was investigated for the first time.

methodsAnti-proliferative activity of EEP, HPE and their combination (EEP + HPE) was determined by a cytotoxicity test, DNA binding by [(3)H]-thymidine incorporation and cell migration assay. Anti-metastatic properties in U87MG treated with EEP, HPE and EEP + HPE were estimated on cells migration test (scratch assay) and metalloproteinases (MMP2 and MMP9) secretion (gelatin zymography).

resultsCombination of HPE and EEP extracts was found to have a time- and dose-dependent inhibitory effect on the viability of U87MG cells. This effect was significantly higher (p < 0.05) when compared to these two extracts applied separately, which was confirmed by the significant reduction of DNA synthesis and significantly higher mitochondrial membrane permeabilization. A significant decreasing in migration cells and in pro-MMP9 and pro-MMP2 secretion in U87MG cells were demonstrated after exposure to combination of EEP (30 μg/ml) with HPE (6.25 μg/ml).

conclusionsIn this study, the combination of ethanolic extract from propolis and ethanolic extract of fresh-cut H. perforatum L. was proved the ability to reduce invasiveness of glioma cells through the inhibition of MMP2 and MMP9 secretion and suppression of cell migration. It has a more potent anti-proliferative effect on U87MG glioma cell line compared to using propolis and H. perforatum L. separately. Further studies are required to verify whether the examined extracts can activate apoptotic pathways.

Indexed as

Antineoplastic AgentsCell Line, TumorCell MovementCell ProliferationGlioblastomaHumansHypericumPlant ExtractsPropolisAntineoplastic AgentsPlant ExtractsPropolisGlioblastoma multiformeH. perforatum L.Propolis

Identifiers

PMID27647142
PMCPMC5029078
OpenAlexW2523728590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.